Literature DB >> 758452

South American plants II: taspine isolation and anti-inflammatory activity.

G P Perdue, R N Blomster, D A Blake, N R Farnsworth.   

Abstract

Croton lechleri L. (Euphorbiaceae), a plant from the Upper Amazon Valley of Peru, yielded the alkaloid taspine. The anti-inflammatory activity of taspine hydrochloride was studied using the carrageenan-induced pedal edema method, the cotton pellet-induced granuloma method, and the adjuvant polyarthritis model.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 758452     DOI： 10.1002/jps.2600680145

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


  5 in total

1.  Taspine: bioactivity-guided isolation and molecular ligand-target insight of a potent acetylcholinesterase inhibitor from Magnolia x soulangiana.

Authors:  Judith M Rollinger; Daniela Schuster; Elisabeth Baier; Ernst P Ellmerer; Thierry Langer; Hermann Stuppner
Journal:  J Nat Prod       Date:  2006-09       Impact factor: 4.050

2.  Efficacy of Dragon's blood cream on wound healing: A randomized, double-blind, placebo-controlled clinical trial.

Authors:  Foroogh Namjoyan; Fatemeh Kiashi; Zahra Beigom Moosavi; Fatemeh Saffari; Behzad Sharif Makhmalzadeh
Journal:  J Tradit Complement Med       Date:  2015-01-22

3.  Identification of a novel topoisomerase inhibitor effective in cells overexpressing drug efflux transporters.

Authors:  Walid Fayad; Mårten Fryknäs; Slavica Brnjic; Maria Hägg Olofsson; Rolf Larsson; Stig Linder
Journal:  PLoS One       Date:  2009-10-02       Impact factor: 3.240

4.  Antiviral Activity of Metabolites from Peruvian Plants against SARS-CoV-2: An In Silico Approach.

Authors:  Luis Daniel Goyzueta-Mamani; Haruna Luz Barazorda-Ccahuana; Karel Mena-Ulecia; Miguel Angel Chávez-Fumagalli
Journal:  Molecules       Date:  2021-06-25       Impact factor: 4.411

Review 5.  Genus caulophyllum: an overview of chemistry and bioactivity.

Authors:  Yong-Gang Xia; Guo-Yu Li; Jun Liang; Bing-You Yang; Shao-Wa Lü; Hai-Xue Kuang
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-04       Impact factor: 2.629
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.